Franklin Limited Duration Income Trust Declares Monthly Dividend
Jan 19, 2017 21:05 pm UTC| Business
SAN MATEO, Calif., Jan. 19, 2017 -- Franklin Limited Duration Income Trust (NYSE MKT:FTF), a closed-end investment company managed by Franklin Advisers, Inc., announced today a dividend of $0.1086 per common share,...
Micron Technology to Host Analyst Conference
Jan 19, 2017 21:05 pm UTC| Business
BOISE, Idaho, Jan. 19, 2017 -- Micron Technology, Inc. (NASDAQ:MU) will host an analyst conference on Thursday, February 2, 2017. Presentations by Micron executives will begin at 9 a.m. MT and the event is expected to...
Affimed Announces Proposed Public Offering of Common Stock
Jan 19, 2017 21:04 pm UTC| Business
Heidelberg, Germany January 19, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced that it has...
Stemline Therapeutics Announces Proposed Public Offering of Common Stock
Jan 19, 2017 21:04 pm UTC| Business
NEW YORK, Jan. 19, 2017 -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced that it intends to offer and sell, subject to...
Affimed Announces Proposed Public Offering of Common Stock
Jan 19, 2017 21:02 pm UTC| Business
Affimed N.V. (Nasdaq:AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced that it has commenced an underwritten public offering of...
Jan 19, 2017 21:01 pm UTC| Business
KILGORE, Texas, Jan. 19, 2017 -- Martin Midstream Partners L.P. (NASDAQ:MMLP) announced today it has declared a quarterly cash distribution of $0.50 per unit, or $2.00 per unit on an annualized basis, for the quarter...
Avinger Announces Presentations Showcasing Lumivascular Technology at Leipzig Interventional Course
Jan 19, 2017 21:01 pm UTC| Business
REDWOOD CITY, Calif., Jan. 19, 2017 -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced a schedule of abstracts and sessions highlighting the...